Clinical case of musculoskeletal system disorder in patients with COVID-19

The pandemic of coronavirus 2 (severe acute respiratory syndrome (SARSCoV-2) has significantly changed lives around the world. Musculoskeletal symptoms can develop with SARS-CoV-2 as other infections. Viral infections be cause arthritis, but spectrum quite wide, from arthralgia to chronic arthritis. Coronaviruses usually and myalgia rather than clinical However, a dysregulation systemic overactivation immune system, described cytokine storm or hyperinflammatory syndrome, developduring course COVID-19. As result, coagulation inflammation affect progression disease possibly lead damageof musculoskeletal system.The aim publication is raise awareness rheumatologists general practitioners, we offer case development system lesion in patient COVID-19 successful treatment this condition patient.Patients methods. article presents Z., who was diagnosed joint lesions on background infection.The hospitalized rheumatology department Communal Non-profit Enterprise Kharkov Regional Council «Kharkiv RegionalHospital».Results discussion. underwent full range diagnostic studies prescribed therapy corticosteroids,supportive, well antibiotic therapy. decrease damage noted during Subsequent observation indicatedan improvement patient’s after end hospital.Conclusions. Our own experience management against infection presens article. data cases that were accompanied by occurred some time viral presented. Important practical issues related diagnosis patients withatypical manifestations are considered.